Cat.#: ACPP-1233
| Despition | Galectin 3 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1530 | Mouse METRN Protein (AC1530) | 1 µg | inquiry |
| ACPP-1279 | NEDD4 Blocking Peptide (AC1279) | 250 µg | inquiry |
| ACPP-1606 | Human GAD2 Protein (AC1606) | 50 µg | inquiry |
| ACPP-1516 | Human Insulin Protein, Yeast (AC1516) | 2 mg | inquiry |
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
| ACPP-1470 | Human CLTA Protein (AC1470) | 5 µg | inquiry |
| ACPP-1308 | TrkA Blocking Peptide (AC1308) | 250 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
| ACPP-1023 | Synthetic Nanodisc Human KCNK9 Protein (AC1023) | 10 µg | inquiry |
| ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.